Results 81 to 90 of about 6,454 (214)

Non toxic goiter in the adult population of Genoa: 10 years of experience

, 2012
The aim of this study was to assess the prevalence of non toxic goiter, diffuse or nodular, in all Genoa?s Country thyroid diseases. The Authors have studied one non-random casuistry of 1980 Patients observed from time to time in the last decade in ...
Armonino, R, Santaniello, B, Lombardo, I, Niccolardi, ME   +3 more
core   +1 more source

[Nodular toxic goiter in children: clinical features, morphological variants]. [PDF]

Probl Endokrinol (Mosk), 2021
Ivannikova TE, Bezlepkina OB, Abdulhabirova FM, Abrosimov AU, Degtyarev MV, Zubkova NA.   +5 more
europepmc   +1 more source

Effect of Somatostatin on TSH Levels in Non-Toxic Sporadic Goiter

, 1990
Summary Somatostatin (SS-14; growth hormone-release inhibiting hormone) was infused into eight patients with non-toxic sporadic goiter and into eleven normal control subjects.
Avila, C, Coloma, M. J, Varea, J, Briones, R, Schally, A. V, Garces, G, Paredes, M, Ochoa, C, Comaru-Schally, A. M   +8 more
core   +1 more source

The influence of thyroid disorders on the state of brain’s bioelectrical activity in pregnant women

Mìžnarodnij Endokrinologìčnij Žurnal
Background. Thyroid disease is the second most common endocrine disorder after diabetes in pregnancy. Thyroid hormones are crucial for the growth and maturation of many target tissues, especially the brain and skeleton.
O.S. Paienok, A.V. Paienok, B.V. Zadorozhna, B.R. Hrytsyshyn, S.V. Ihnatovych   +4 more
doaj   +1 more source

RADIONUCLIDE SCANNING WITH I-123 IN GRAVES DISEASE

e-Jurnal Medika Udayana, 2014
Graves’ disease is the most common form of thyrotoxicosis which caused byautoimmune that attacks the thyroid gland. This disease will lead such followingsyndromes: thyrotoxicosis, goiter, ophthalmopathy, dermopathy.
Putu Diah Vedayanti, Lisna Astuti, Elisanti Dwi Martadiani   +2 more
doaj  

Complicated course of diffuse toxic goiter in a puberty patient (clinical observation)

, 2021
In the above clinical observation, attention is drawn to the late diagnosis and inadequate treatment of diffuse toxic goiter in a puberty patient, which lead to a fatal outcome due to the formation of severe ...
V. G. Chobitko, Kh. K. Makhasheva
core  

How the Dose of Iodine-131 Should be Determined in the Treatment of Graves' and Toxic Nodular Hyperthyroidism

Siriraj Medical Journal, 2005
Despite the wide use of radioiodine treatment for hyperthyroidism, the best approach to radioiodine dose selection in the treatment remains controversial.
Sunanta Chiewvit, Chiraporn Tocharoenchai, Chulaluk Kolmoltri   +2 more
doaj  

How the Dose of Iodine-131 Should be Determined in the Treatment of Graves' and Toxic Nodular Hyperthyroidism

Siriraj Medical Journal, 2004
Despite the wide use of radioiodine treatment for hyperthyroidism, the best approach to radioiodine dose selection in the treatment remains controversial.
Sunanta Chiewvit, Chiraporn Tocharoenchai, Chulaluk Kolmoltri   +2 more
doaj  

Valores de linfocitos T Activos en pacientes con Bocio Tóxico difuso (Graves-Basedow)

Revista Colombiana de Endocrinología, Diabetes y Metabolismo, 2018
Los valores de linfocitos T de alta afinidad por los glóbulos rojos de carnero (linfocitos T activos) están significativamente disminuídos en pacientes con Bocio Tóxico Difuso (BTD), lo que sugiere una evidencia más, de alteración de la inmunidad ...
Angel Uriarte, Ernesto Alavez
doaj   +1 more source

Standard dose 131 I therapy for toxic multinodular goiter in an endemic goiter region

, 1986
1. The effect of the standard 15 mCi dose of 131 I on the thyroid function of 25 patients from an endemic goiter region with toxic multinodular goiter of different sizes was determined. 2. The patients were followed for 1 to 5 years and 7 months (mean: 2
Gonçalves, E., Gross, Jorge Luiz, Castro, Jose Augusto Sisson de   +2 more
core